Transcutaneous electrical stimulation (TENS) for psychogenic movement disorders
Joseph Ferrara1, William Stamey, Adriana M Strutt
1Parkinson Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA. josephj@bcm.tmc.edu
Transcutaneous electrical nerve stimulation (TENS) offers a safe, palliative treatment option for psychogenic movement disorders (PMDs). Patients with shorter duration PMDs experienced significant symptom improvement with TENS therapy.
Area of Science:
- Neurology
- Physical Medicine and Rehabilitation
Background:
- Psychogenic movement disorders (PMDs) significantly impair quality of life.
- Current medical therapies for PMDs are limited and often ineffective.
Purpose of the Study:
- To investigate the efficacy of transcutaneous electrical nerve stimulation (TENS) as a treatment for patients with PMDs.
- To identify predictors of favorable outcomes in PMD patients receiving TENS.
Main Methods:
- A study involving 19 patients diagnosed with PMDs.
- Utilized the Psychogenic Movement Disorder Rating Scale (PMDRS) and patient-reported assessments.
- Assessed outcomes after a mean follow-up of 6.9 months.
Main Results:
- Significant improvement in the PMDRS Severity score was observed.
- Shorter duration of PMD was the sole predictor of a positive treatment response.
- TENS demonstrated a favorable side-effect profile.
Conclusions:
- TENS can be an acceptable palliative treatment for a subset of patients with psychogenic movement disorders.
- The study highlights the potential of TENS despite challenges in conducting controlled trials due to sensory side effects.
More Related Videos
08:22Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
12:13Assessing Primary Motor Cortex Excitability and Excitability Modulation by Pairing Transcranial Magnetic Stimulation with Electromyography
Published on: October 7, 2025
